SlideShare a Scribd company logo
1 of 22
CONTROL AND PREVENTION OF
INFLUENZA
Influenza is a contagious respiratory
illness caused by influenza virus.
Worldwide seasonal influenza kills
2,50,000 -5,00,000 people each year.
 antigenic shift & drift properties of
influenza virus are responsible for
emergence of new viral pathogens &
normal flu seasons.
 ANTIGENIC SHIFT :two or
more different strains of virus
combine to form a new
subtype,with a mixture of
surface antigens of the two or
more original strains.
 ANTIGENIC DRIFT : small
mutations in hemagglutinin
& neuraminidase genes that
make protein unrecognizable
to pre-existing host
immunity.This leads to
continous process of genetic
& antigenic changes among
flu strains.
 Influenza transmission is by 3 ways :
1. Direct transmission into the mucous
membrane of a person .
2. Airborne route – that is via droplets
.(0.5-5 microm diameter)
3. Contaminated surfaces, handles
etc…
CONTROL OF INFLUENZA
INFECTION CONTROL
 Infection control includes :
Good personal health &
hygiene.
Frequent handwashing
with water & soap or
alcohol ( effective sanitizer
against influenza )
Covering cough and
sneezes.
Avoiding close contact
with infected persons.
ANTIVIRAL DRUGS
 Lessens symptoms.
 Prevents flu related complications like pneumonia,
bronchitis, sinus infections,ear infections.
 Two antiviral drugs:
a. Oseltamivir( brand name- tamiflu) : form of
pills/tablets
b. Zanemivir (brand name – relenza) : form of inhaled
powder.
Given for a duration of 5 days.
PREVENTION OF INFLUENZA
 Influenza vaccines based on concept of herd immunity. .ie,
80% population should be immune to a disease.
 There are two flu seasons annually , corresponding to
occurrence of winter in opposite months in northern &
southern hemisphere.
 Annual reformulation of flu vaccine : each yr 3 influenza
strains(trivalent) that will be most common during
upcoming season are incorporated. This is based on
research by WHO s “Global influenza surveillance
network”.
 Upcoming seasonal flu vaccines contain H1N1, H3N2 and
influenza B strains.
vaccination
 Two types of vaccines are
available:
a. Flu shots
b. Nasal spray flu vaccine
(LAIV – live attenuated
influenza vaccine )
DNA based vaccines are in
clinical trial.
 FLU SHOT:
o Inactivated vaccine (
containing killed virus)
o Approved for > 6 months old,
including healthy people &
people with chronic medical
conditions.
o 3 different types :
i. Regular dose for 6 months
and older
ii. High dose > 65yrs
iii. Intermediate flu shot (18-
64 yrs.)
 NASAL SPRAY FLU VACCINES :
Live weakened flu viruses.
LAIV
Healthy people ( 2-49 yrs)
 People at high risk of
developing flu related
complications are
potential candidates of
influenza vaccine.
1. Children < 5yrs ;
especially < 2 yrs
2. Older people >65 yrs.
3. Pregnant women
4. Medical conditions like
 Asthma, heart disease
 Blood disorders like sickle cell anaemia
 Liver disorders , kidney disorders
 Endocrine disorders like diabetes mellitus.
 Metabolic disorders ( inherited metabolic disorders or
mitochondrial isorders)
 Immunocompromised states – HIV/AIDS; prolonged
steroid therapy; malignancies.
 Morbidly obese (BMI > 40)
 Long term aspirin therapy.
Side effects of vaccine
 INJECTIONS:
Mild soreness,redness and swelling at the injection site.
Fever
Aches
Guillian barre syndrome (rare)
• NASAL SPRAY :
 Nasal congestion, running nose
 Cough, wheezing
 Fever
 Headache, myalgia
 Allergic reaction
 Abdominal pain ( more so in children )
 CONTRAINDICATIONS :
I. Severe reaction to influenza vaccination in <6
months.
II. Severe allergy to chicken eggs that is used to grow
the virus strains.
III. Moderate to severe illness with fever.
IV. History of Guillian barre syndrome.
WHO RECOMMENDATIONS
 Get yourself & your
family members (> 6
months of age )
vaccinated against
current strains of
influenza.
 Keep distance from
people with symptoms
of influenza like illness,
coughing & sneezing
 Clean hands thoroughly with
soap & water/ alcohol based
hand rub on regular basis.
 Avoid touching your mouth ,
nose , eyes as much as
possible.
 Reduce time spent in
crowded places.
 Improve airflow in our living
spaces by opening windows.
 Practice good health habits
(adequate sleep, nutritious
food ,keeping physically
active).
CDC RECOMMENDATIONS
 Cover nose & mouth with
tissue when coughing /
sneezing.
 Wash hands with soap &
water especially after
coughing &
sneezing.alcohol based
cleansers are also effective.
 Avoid touching eyes
,mouth, nose to avoid
spread of germs.
 Try to avoid close contact
with sick people.
 Those sick with flu like
illness should stay at
home until fever has
subsided > 24 hrs.
Control and prevention_of_influenza

More Related Content

What's hot

Severe Acute Respiratory Syndrome (SARS)
Severe Acute Respiratory Syndrome (SARS)Severe Acute Respiratory Syndrome (SARS)
Severe Acute Respiratory Syndrome (SARS)University Of Lahore
 
Severe Acute Respiratory Syndrome (SARS) : Treatment and prophylaxis with Re...
Severe Acute Respiratory Syndrome (SARS)  : Treatment and prophylaxis with Re...Severe Acute Respiratory Syndrome (SARS)  : Treatment and prophylaxis with Re...
Severe Acute Respiratory Syndrome (SARS) : Treatment and prophylaxis with Re...Dmitri Popov
 
Concept of prevention and control of disease
Concept of prevention and control of diseaseConcept of prevention and control of disease
Concept of prevention and control of diseaseAshish Chaudhari
 
National tobacco control program (ntcp) in india
National tobacco control program (ntcp) in india National tobacco control program (ntcp) in india
National tobacco control program (ntcp) in india AhmadAbdussalam1
 
Chikungunya fever
Chikungunya feverChikungunya fever
Chikungunya feverArifa T N
 
Universal Immunisation Programme.pptx
Universal Immunisation Programme.pptxUniversal Immunisation Programme.pptx
Universal Immunisation Programme.pptxEasy Concept
 
Evolution of public health.pptx ug
Evolution of public health.pptx ugEvolution of public health.pptx ug
Evolution of public health.pptx ugSachin Patne
 
Chapter 6.1 national tobacco control program
Chapter 6.1 national tobacco control programChapter 6.1 national tobacco control program
Chapter 6.1 national tobacco control programNilesh Kucha
 
Influenza facts and prevention
Influenza facts and preventionInfluenza facts and prevention
Influenza facts and preventionMoustapha Ramadan
 
CONCEPTS OF PREVENTION AND CONTROL
CONCEPTS OF PREVENTION AND CONTROLCONCEPTS OF PREVENTION AND CONTROL
CONCEPTS OF PREVENTION AND CONTROLSnehlata Parashar
 
1.Definition, concepts and evaluation of public health. .ppt
1.Definition, concepts and evaluation of public health. .ppt1.Definition, concepts and evaluation of public health. .ppt
1.Definition, concepts and evaluation of public health. .pptShikha Baghel Chauhan
 
Social and preventive pharmacy
Social and preventive pharmacySocial and preventive pharmacy
Social and preventive pharmacyVarshaBarethiya
 

What's hot (20)

Influenza disease
Influenza diseaseInfluenza disease
Influenza disease
 
Severe Acute Respiratory Syndrome (SARS)
Severe Acute Respiratory Syndrome (SARS)Severe Acute Respiratory Syndrome (SARS)
Severe Acute Respiratory Syndrome (SARS)
 
Sars
SarsSars
Sars
 
Severe Acute Respiratory Syndrome (SARS) : Treatment and prophylaxis with Re...
Severe Acute Respiratory Syndrome (SARS)  : Treatment and prophylaxis with Re...Severe Acute Respiratory Syndrome (SARS)  : Treatment and prophylaxis with Re...
Severe Acute Respiratory Syndrome (SARS) : Treatment and prophylaxis with Re...
 
Concept of prevention and control of disease
Concept of prevention and control of diseaseConcept of prevention and control of disease
Concept of prevention and control of disease
 
Prevention and control of dengue fever
Prevention and control of dengue feverPrevention and control of dengue fever
Prevention and control of dengue fever
 
Lymphatic filariasis
Lymphatic filariasisLymphatic filariasis
Lymphatic filariasis
 
National tobacco control program (ntcp) in india
National tobacco control program (ntcp) in india National tobacco control program (ntcp) in india
National tobacco control program (ntcp) in india
 
Chikungunya fever
Chikungunya feverChikungunya fever
Chikungunya fever
 
Sars updates
Sars   updatesSars   updates
Sars updates
 
Universal Immunisation Programme.pptx
Universal Immunisation Programme.pptxUniversal Immunisation Programme.pptx
Universal Immunisation Programme.pptx
 
Ebola virus
Ebola virusEbola virus
Ebola virus
 
Evolution of public health.pptx ug
Evolution of public health.pptx ugEvolution of public health.pptx ug
Evolution of public health.pptx ug
 
Chapter 6.1 national tobacco control program
Chapter 6.1 national tobacco control programChapter 6.1 national tobacco control program
Chapter 6.1 national tobacco control program
 
Influenza facts and prevention
Influenza facts and preventionInfluenza facts and prevention
Influenza facts and prevention
 
CONCEPTS OF PREVENTION AND CONTROL
CONCEPTS OF PREVENTION AND CONTROLCONCEPTS OF PREVENTION AND CONTROL
CONCEPTS OF PREVENTION AND CONTROL
 
Ebola virus ppt
Ebola virus pptEbola virus ppt
Ebola virus ppt
 
1.Definition, concepts and evaluation of public health. .ppt
1.Definition, concepts and evaluation of public health. .ppt1.Definition, concepts and evaluation of public health. .ppt
1.Definition, concepts and evaluation of public health. .ppt
 
Social and preventive pharmacy
Social and preventive pharmacySocial and preventive pharmacy
Social and preventive pharmacy
 
Lymphatic filariasis
Lymphatic filariasisLymphatic filariasis
Lymphatic filariasis
 

Similar to Control and prevention_of_influenza (20)

Lesson plan on influenza
Lesson plan on influenzaLesson plan on influenza
Lesson plan on influenza
 
Influenza
InfluenzaInfluenza
Influenza
 
Influenza, Department of Physiotherapy, SHUATS, Prayagraj
Influenza, Department of Physiotherapy, SHUATS, PrayagrajInfluenza, Department of Physiotherapy, SHUATS, Prayagraj
Influenza, Department of Physiotherapy, SHUATS, Prayagraj
 
Swine Flu Final
Swine Flu FinalSwine Flu Final
Swine Flu Final
 
Influenz1.docx
Influenz1.docxInfluenz1.docx
Influenz1.docx
 
Swine Flu Final
Swine Flu FinalSwine Flu Final
Swine Flu Final
 
influenza - by nursing students
influenza - by nursing studentsinfluenza - by nursing students
influenza - by nursing students
 
EPIDEMIOLOGY – COMMUNICABLE DISEASE.pptx
EPIDEMIOLOGY – COMMUNICABLE DISEASE.pptxEPIDEMIOLOGY – COMMUNICABLE DISEASE.pptx
EPIDEMIOLOGY – COMMUNICABLE DISEASE.pptx
 
swine Flu Influenza Pptx
swine Flu Influenza Pptxswine Flu Influenza Pptx
swine Flu Influenza Pptx
 
2009 Sept 1 Nwrc H1 N1
2009 Sept 1 Nwrc H1 N12009 Sept 1 Nwrc H1 N1
2009 Sept 1 Nwrc H1 N1
 
Pra.ppt
Pra.pptPra.ppt
Pra.ppt
 
Pandemic Flu
Pandemic FluPandemic Flu
Pandemic Flu
 
H1 N1
H1 N1H1 N1
H1 N1
 
Swine flu
Swine fluSwine flu
Swine flu
 
Swine flu ppt
Swine flu pptSwine flu ppt
Swine flu ppt
 
H1 N1
H1 N1H1 N1
H1 N1
 
CHAPTER SEVEN CH.docx
CHAPTER SEVEN CH.docxCHAPTER SEVEN CH.docx
CHAPTER SEVEN CH.docx
 
CHAPTER SEVEN CH.docx
CHAPTER SEVEN CH.docxCHAPTER SEVEN CH.docx
CHAPTER SEVEN CH.docx
 
Novel H1 N1 Flu Infection
Novel H1 N1 Flu InfectionNovel H1 N1 Flu Infection
Novel H1 N1 Flu Infection
 
C05 P08 INFLUENZA.ppt
C05 P08 INFLUENZA.pptC05 P08 INFLUENZA.ppt
C05 P08 INFLUENZA.ppt
 

More from Chandan N

Universal & transmission precaution
Universal & transmission precautionUniversal & transmission precaution
Universal & transmission precautionChandan N
 
Coronory angiography
Coronory angiographyCoronory angiography
Coronory angiographyChandan N
 
Anasthesia during cpb
Anasthesia during cpbAnasthesia during cpb
Anasthesia during cpbChandan N
 
Reducing stroke in AF
Reducing stroke in AFReducing stroke in AF
Reducing stroke in AFChandan N
 
Antiplatelet and arterial thrombosis
Antiplatelet and arterial thrombosisAntiplatelet and arterial thrombosis
Antiplatelet and arterial thrombosisChandan N
 
Anticoagulant in DVT and APE
Anticoagulant in DVT and APEAnticoagulant in DVT and APE
Anticoagulant in DVT and APEChandan N
 
Antibiotics use and overuse
Antibiotics use and overuse Antibiotics use and overuse
Antibiotics use and overuse Chandan N
 
Renal failure
Renal failureRenal failure
Renal failureChandan N
 
Non hodgkins lymphoma
Non hodgkins lymphomaNon hodgkins lymphoma
Non hodgkins lymphomaChandan N
 
Non hodgkins lymphoma
Non hodgkins lymphomaNon hodgkins lymphoma
Non hodgkins lymphomaChandan N
 
Final housestaff opportunistic infections lecture
Final housestaff opportunistic infections lectureFinal housestaff opportunistic infections lecture
Final housestaff opportunistic infections lectureChandan N
 
Diabetes in pregnancy
Diabetes in pregnancyDiabetes in pregnancy
Diabetes in pregnancyChandan N
 
Chronic renal failure
Chronic renal failureChronic renal failure
Chronic renal failureChandan N
 
Advances in hiv treatment
Advances in hiv treatmentAdvances in hiv treatment
Advances in hiv treatmentChandan N
 
Acute renal failure
Acute renal failureAcute renal failure
Acute renal failureChandan N
 
Abnormal puerperium
Abnormal puerperiumAbnormal puerperium
Abnormal puerperiumChandan N
 

More from Chandan N (20)

Universal & transmission precaution
Universal & transmission precautionUniversal & transmission precaution
Universal & transmission precaution
 
Coronory angiography
Coronory angiographyCoronory angiography
Coronory angiography
 
Anasthesia during cpb
Anasthesia during cpbAnasthesia during cpb
Anasthesia during cpb
 
Reducing stroke in AF
Reducing stroke in AFReducing stroke in AF
Reducing stroke in AF
 
Antiplatelet and arterial thrombosis
Antiplatelet and arterial thrombosisAntiplatelet and arterial thrombosis
Antiplatelet and arterial thrombosis
 
Anticoagulant in DVT and APE
Anticoagulant in DVT and APEAnticoagulant in DVT and APE
Anticoagulant in DVT and APE
 
Antibiotics use and overuse
Antibiotics use and overuse Antibiotics use and overuse
Antibiotics use and overuse
 
Acute mi
Acute miAcute mi
Acute mi
 
Renal failure
Renal failureRenal failure
Renal failure
 
Nutrition
NutritionNutrition
Nutrition
 
Non hodgkins lymphoma
Non hodgkins lymphomaNon hodgkins lymphoma
Non hodgkins lymphoma
 
Non hodgkins lymphoma
Non hodgkins lymphomaNon hodgkins lymphoma
Non hodgkins lymphoma
 
ckd
ckdckd
ckd
 
Nhl
NhlNhl
Nhl
 
Final housestaff opportunistic infections lecture
Final housestaff opportunistic infections lectureFinal housestaff opportunistic infections lecture
Final housestaff opportunistic infections lecture
 
Diabetes in pregnancy
Diabetes in pregnancyDiabetes in pregnancy
Diabetes in pregnancy
 
Chronic renal failure
Chronic renal failureChronic renal failure
Chronic renal failure
 
Advances in hiv treatment
Advances in hiv treatmentAdvances in hiv treatment
Advances in hiv treatment
 
Acute renal failure
Acute renal failureAcute renal failure
Acute renal failure
 
Abnormal puerperium
Abnormal puerperiumAbnormal puerperium
Abnormal puerperium
 

Recently uploaded

Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalityhardikdabas3
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxdrashraf369
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 

Recently uploaded (20)

Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortality
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptx
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 

Control and prevention_of_influenza

  • 1. CONTROL AND PREVENTION OF INFLUENZA
  • 2. Influenza is a contagious respiratory illness caused by influenza virus. Worldwide seasonal influenza kills 2,50,000 -5,00,000 people each year.  antigenic shift & drift properties of influenza virus are responsible for emergence of new viral pathogens & normal flu seasons.
  • 3.  ANTIGENIC SHIFT :two or more different strains of virus combine to form a new subtype,with a mixture of surface antigens of the two or more original strains.  ANTIGENIC DRIFT : small mutations in hemagglutinin & neuraminidase genes that make protein unrecognizable to pre-existing host immunity.This leads to continous process of genetic & antigenic changes among flu strains.
  • 4.  Influenza transmission is by 3 ways : 1. Direct transmission into the mucous membrane of a person . 2. Airborne route – that is via droplets .(0.5-5 microm diameter) 3. Contaminated surfaces, handles etc…
  • 5.
  • 7. INFECTION CONTROL  Infection control includes : Good personal health & hygiene. Frequent handwashing with water & soap or alcohol ( effective sanitizer against influenza ) Covering cough and sneezes. Avoiding close contact with infected persons.
  • 8. ANTIVIRAL DRUGS  Lessens symptoms.  Prevents flu related complications like pneumonia, bronchitis, sinus infections,ear infections.  Two antiviral drugs: a. Oseltamivir( brand name- tamiflu) : form of pills/tablets b. Zanemivir (brand name – relenza) : form of inhaled powder. Given for a duration of 5 days.
  • 10.  Influenza vaccines based on concept of herd immunity. .ie, 80% population should be immune to a disease.  There are two flu seasons annually , corresponding to occurrence of winter in opposite months in northern & southern hemisphere.  Annual reformulation of flu vaccine : each yr 3 influenza strains(trivalent) that will be most common during upcoming season are incorporated. This is based on research by WHO s “Global influenza surveillance network”.  Upcoming seasonal flu vaccines contain H1N1, H3N2 and influenza B strains.
  • 11. vaccination  Two types of vaccines are available: a. Flu shots b. Nasal spray flu vaccine (LAIV – live attenuated influenza vaccine ) DNA based vaccines are in clinical trial.
  • 12.  FLU SHOT: o Inactivated vaccine ( containing killed virus) o Approved for > 6 months old, including healthy people & people with chronic medical conditions. o 3 different types : i. Regular dose for 6 months and older ii. High dose > 65yrs iii. Intermediate flu shot (18- 64 yrs.)
  • 13.  NASAL SPRAY FLU VACCINES : Live weakened flu viruses. LAIV Healthy people ( 2-49 yrs)
  • 14.  People at high risk of developing flu related complications are potential candidates of influenza vaccine. 1. Children < 5yrs ; especially < 2 yrs 2. Older people >65 yrs. 3. Pregnant women
  • 15. 4. Medical conditions like  Asthma, heart disease  Blood disorders like sickle cell anaemia  Liver disorders , kidney disorders  Endocrine disorders like diabetes mellitus.  Metabolic disorders ( inherited metabolic disorders or mitochondrial isorders)  Immunocompromised states – HIV/AIDS; prolonged steroid therapy; malignancies.  Morbidly obese (BMI > 40)  Long term aspirin therapy.
  • 16. Side effects of vaccine  INJECTIONS: Mild soreness,redness and swelling at the injection site. Fever Aches Guillian barre syndrome (rare) • NASAL SPRAY :  Nasal congestion, running nose  Cough, wheezing  Fever  Headache, myalgia  Allergic reaction  Abdominal pain ( more so in children )
  • 17.  CONTRAINDICATIONS : I. Severe reaction to influenza vaccination in <6 months. II. Severe allergy to chicken eggs that is used to grow the virus strains. III. Moderate to severe illness with fever. IV. History of Guillian barre syndrome.
  • 18. WHO RECOMMENDATIONS  Get yourself & your family members (> 6 months of age ) vaccinated against current strains of influenza.  Keep distance from people with symptoms of influenza like illness, coughing & sneezing
  • 19.  Clean hands thoroughly with soap & water/ alcohol based hand rub on regular basis.  Avoid touching your mouth , nose , eyes as much as possible.  Reduce time spent in crowded places.  Improve airflow in our living spaces by opening windows.  Practice good health habits (adequate sleep, nutritious food ,keeping physically active).
  • 20. CDC RECOMMENDATIONS  Cover nose & mouth with tissue when coughing / sneezing.  Wash hands with soap & water especially after coughing & sneezing.alcohol based cleansers are also effective.  Avoid touching eyes ,mouth, nose to avoid spread of germs.
  • 21.  Try to avoid close contact with sick people.  Those sick with flu like illness should stay at home until fever has subsided > 24 hrs.